Drugs & Targets FDA issues CRL for RP1+ nivolumab BLA for treatment of advanced melanoma July 25, 2025Vol.51 No.29
Drugs & Targets FDA grants Breakthrough Therapy designation to elironrasib for lung cancer July 25, 2025Vol.51 No.29
Drugs & Targets EMA grants Orphan Drug designation for ICT01 as treatment for AML July 25, 2025Vol.51 No.29
Regulatory News ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population July 18, 2025Vol.51 No.28By Jacquelyn Cobb and Sara Willa Ernst
Cancer Policy NIH says it’s moving away from animal-based models July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy Trump threatens tariffs on Big Pharma by Aug. 1 July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy CMS publishes Medicare physician fee schedule proposal July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy CMS proposes policy to move away from hospital-based care July 18, 2025Vol.51 No.28By Claire Marie Porter
